To evaluate clinical outcomes of surgical intervention in patients with intrathoracic pseudomyxoma peritonei (PMP), a rare condition, and review existing literature.
Key Findings:
All patients had low-grade PMP with significant pleural effusion and pulmonary lesions.
1- and 3-year survival rates were 100% and 33.3%, respectively, indicating a concerning drop in long-term survival.
Cytoreductive surgery combined with HITHOC may alleviate symptoms and improve prognostic outcomes, but further validation is needed.
Interpretation:
Intrathoracic PMP is rare and associated with poor prognosis; however, surgical intervention can provide symptom relief and potentially enhance survival, though the long-term benefits remain uncertain.
Limitations:
Small sample size limits generalizability.
Retrospective nature may introduce bias.
Lack of a control group for comparison.
Conclusion:
Surgical management of intrathoracic PMP can be beneficial, but careful monitoring for complications is essential, and further research is needed to validate these findings.
